Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
2,734,292
-
Share change
-
-53,440
-
Total reported value
-
$21,923,000
-
Price per share
-
$7.91
-
Number of holders
-
10
-
Value change
-
-$365,239
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of SUMMIT THERAPEUTICS INC COM - Stock (SMMT) as of Q2 2016
As of 30 Jun 2016,
SUMMIT THERAPEUTICS INC COM - Stock (SMMT) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,734,292 shares.
The largest 10 holders included
LANSDOWNE PARTNERS (UK) LLP, Point72 Asset Management, L.P., AXA, SPHERA FUNDS MANAGEMENT LTD., First Eagle Investment Management, LLC, Granite Point Capital Management, L.P., DEUTSCHE BANK AG\, UBS Group AG, Tower Research Capital LLC (TRC), and WELLS FARGO & COMPANY/MN.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.